Skip to main content

Technological offer

Available technologies catalogue

Available Technological Offer

Technological category
New marine-origin Cas9 nucleases for genetic editing using the CRISPR-Cas system, with applications ranging from gene therapy to the improvement of plant and animal organisms.
Two different vaccines prototypes have been developed based on RNA replicons from SARS-CoV-2 and MERS-CoV, encapsulated in Virus-Like Particles (VLPs), which can be used as a vaccines to generate immunity and protect against infections by these coronavirus.

Social Media